Negative Equity

Showing 1961 articles
Business

Arcellx Stock: A Tale of Two Valuations Amid Biotech Volatility

Arcellx (ACLX) shares are caught in a tug-of-war between conflicting valuation signals. While a sky-high price-to-book ratio suggests the stock is richly valued, a discounted cash flow model implies massive upside potential. We examine the data behind the biotech's recent price swings and what investors are really betting on.

Business

Three Asian Penny Stocks Defying Market Headwinds in 2026

Amidst a backdrop of stable rates and cautious optimism, a handful of low-priced Asian equities are drawing investor scrutiny for their resilience and strategic positioning. We analyze three such companies navigating property downturns, infrastructure demand, and consumer shifts.